Market Cap 33.22B
Revenue (ttm) 363.71M
Net Income (ttm) -913.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -251.24%
Debt to Equity Ratio 0.43
Volume 3,486,400
Avg Vol 2,638,006
Day's Range N/A - N/A
Shares Out 211.38M
Stochastic %K 96%
Beta 1.03
Analysts Strong Sell
Price Target $164.41

Company Profile

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It also devlops brensocatib, an oral reversible inhibitor of...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 977 9900
Address:
700 US Highway 202/206, Bridgewater, United States
Vikingsstrade
Vikingsstrade Oct. 4 at 5:52 PM
Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve! $NAMM $GSIW $BNTX $INSM
0 · Reply
WAJeff
WAJeff Oct. 4 at 3:32 AM
$INSM What a run
0 · Reply
GolfProLife
GolfProLife Oct. 3 at 5:12 PM
$INSM sold 50 percent of contracts at the second top, holding runners of 7k profit, took 10k profit off the table. 3/3 LFG! Let them runners 🏃 run! 🚀
0 · Reply
JarvisFlow
JarvisFlow Oct. 3 at 5:00 PM
Goldman Sachs has adjusted their stance on Insmed ( $INSM ), setting the rating to Buy with a target price of 121 → 196.
0 · Reply
GolfProLife
GolfProLife Oct. 3 at 4:54 PM
$INSM so it’s currently sitting at the average price target from analysts give a or take a couple of dollars. This may be a point of resistance below $158. Needs to break $158.50 to see $160 day light 💎 🙌 🚀 🌙
0 · Reply
IN0V8
IN0V8 Oct. 3 at 4:42 PM
$INSM Jefferies raises target price to $178 from $148
0 · Reply
GolfProLife
GolfProLife Oct. 3 at 4:38 PM
$INSM I can’t believe this is up 16 percent in the last week off the $135 bounce and it’s not trending yet!
0 · Reply
WAJeff
WAJeff Oct. 3 at 4:34 PM
$INSM $157.74 52 week high. Figured that I was selling right into a breakout.
1 · Reply
highnihilism
highnihilism Oct. 3 at 3:58 PM
$INSM Insmed Trades: 253 | Total $: 1.53 M | 0.57 × 90-Day Avg $: 2.7 M | Call $: 1.23 M | Put $: 305.2 K | Single-Leg: 89% | Multi-Leg: 11% $YINN Direxion Daily FTSE China Bull 3X ETF Trades: 1,565 | Total $: 1.64 M | 0.36 × 90-Day Avg $: 4.51 M | Call $: 1.22 M | Put $: 421.2 K | Single-Leg: 71% | Multi-Leg: 29% $VXX iPath Series B S&P 500 VIX Short-Term Futures ETN Trades: 2,762 | Total $: 2.06 M | 0.30 × 90-Day Avg $: 6.92 M | Call $: 1.22 M | Put $: 846.3 K | Single-Leg: 74% | Multi-Leg: 26% $PPLT Abrdn Physical Platinum Shares ETF Trades: 367 | Total $: 1.25 M | 1.37 × 90-Day Avg $: 910.5 K | Call $: 1.2 M | Put $: 44.2 K | Single-Leg: 78% | Multi-Leg: 22%
0 · Reply
Gwaadin
Gwaadin Oct. 3 at 3:43 PM
$INSM I’m having a hard time being a “responsible” investor with this one. I LOVE this chart, and drug stocks generally, offering very positive backdrop. Here’s to kicking my future self for not buying more…
0 · Reply
Latest News on INSM
Insmed To Present at September Investor Conferences

Aug 21, 2025, 7:00 AM EDT - 6 weeks ago

Insmed To Present at September Investor Conferences


Lung Disease-Focused Insmed 'Must-Own' Name For Investors

Aug 20, 2025, 2:46 PM EDT - 6 weeks ago

Lung Disease-Focused Insmed 'Must-Own' Name For Investors


Josh Brown's Best Stocks in the Market: Insmed

Aug 19, 2025, 1:04 PM EDT - 6 weeks ago

Josh Brown's Best Stocks in the Market: Insmed


US FDA approves Insmed's lung disease drug

Aug 12, 2025, 11:42 AM EDT - 7 weeks ago

US FDA approves Insmed's lung disease drug


Insmed Incorporated (INSM) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 10:20 PM EDT - 2 months ago

Insmed Incorporated (INSM) Q2 2025 Earnings Call Transcript


Is Insmed Stock Overvalued After The 45% Jump?

Jun 16, 2025, 5:05 AM EDT - 3 months ago

Is Insmed Stock Overvalued After The 45% Jump?


Insmed: Company Presses On With Further POC PAH Treatment Data

Jun 10, 2025, 4:30 PM EDT - 4 months ago

Insmed: Company Presses On With Further POC PAH Treatment Data


Insmed's blood pressure drug meets main goal in mid-stage trial

Jun 10, 2025, 7:25 AM EDT - 4 months ago

Insmed's blood pressure drug meets main goal in mid-stage trial


Insmed Incorporated (INSM) Q1 2025 Earnings Call Transcript

May 8, 2025, 2:55 PM EDT - 5 months ago

Insmed Incorporated (INSM) Q1 2025 Earnings Call Transcript


Insmed: Poised For Transformation Beyond ARIKAYCE

Apr 25, 2025, 11:58 AM EDT - 5 months ago

Insmed: Poised For Transformation Beyond ARIKAYCE


Insmed Incorporated (INSM) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 12:50 PM EST - 8 months ago

Insmed Incorporated (INSM) Q4 2024 Earnings Call Transcript


Insmed To Present at March 2025 Investor Conferences

Feb 11, 2025, 8:00 AM EST - 8 months ago

Insmed To Present at March 2025 Investor Conferences


Insmed To Present at December 2024 Investor Conferences

Dec 2, 2024, 8:00 AM EST - 10 months ago

Insmed To Present at December 2024 Investor Conferences


Vikingsstrade
Vikingsstrade Oct. 4 at 5:52 PM
Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve! $NAMM $GSIW $BNTX $INSM
0 · Reply
WAJeff
WAJeff Oct. 4 at 3:32 AM
$INSM What a run
0 · Reply
GolfProLife
GolfProLife Oct. 3 at 5:12 PM
$INSM sold 50 percent of contracts at the second top, holding runners of 7k profit, took 10k profit off the table. 3/3 LFG! Let them runners 🏃 run! 🚀
0 · Reply
JarvisFlow
JarvisFlow Oct. 3 at 5:00 PM
Goldman Sachs has adjusted their stance on Insmed ( $INSM ), setting the rating to Buy with a target price of 121 → 196.
0 · Reply
GolfProLife
GolfProLife Oct. 3 at 4:54 PM
$INSM so it’s currently sitting at the average price target from analysts give a or take a couple of dollars. This may be a point of resistance below $158. Needs to break $158.50 to see $160 day light 💎 🙌 🚀 🌙
0 · Reply
IN0V8
IN0V8 Oct. 3 at 4:42 PM
$INSM Jefferies raises target price to $178 from $148
0 · Reply
GolfProLife
GolfProLife Oct. 3 at 4:38 PM
$INSM I can’t believe this is up 16 percent in the last week off the $135 bounce and it’s not trending yet!
0 · Reply
WAJeff
WAJeff Oct. 3 at 4:34 PM
$INSM $157.74 52 week high. Figured that I was selling right into a breakout.
1 · Reply
highnihilism
highnihilism Oct. 3 at 3:58 PM
$INSM Insmed Trades: 253 | Total $: 1.53 M | 0.57 × 90-Day Avg $: 2.7 M | Call $: 1.23 M | Put $: 305.2 K | Single-Leg: 89% | Multi-Leg: 11% $YINN Direxion Daily FTSE China Bull 3X ETF Trades: 1,565 | Total $: 1.64 M | 0.36 × 90-Day Avg $: 4.51 M | Call $: 1.22 M | Put $: 421.2 K | Single-Leg: 71% | Multi-Leg: 29% $VXX iPath Series B S&P 500 VIX Short-Term Futures ETN Trades: 2,762 | Total $: 2.06 M | 0.30 × 90-Day Avg $: 6.92 M | Call $: 1.22 M | Put $: 846.3 K | Single-Leg: 74% | Multi-Leg: 26% $PPLT Abrdn Physical Platinum Shares ETF Trades: 367 | Total $: 1.25 M | 1.37 × 90-Day Avg $: 910.5 K | Call $: 1.2 M | Put $: 44.2 K | Single-Leg: 78% | Multi-Leg: 22%
0 · Reply
Gwaadin
Gwaadin Oct. 3 at 3:43 PM
$INSM I’m having a hard time being a “responsible” investor with this one. I LOVE this chart, and drug stocks generally, offering very positive backdrop. Here’s to kicking my future self for not buying more…
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 3:38 PM
$INSM: Unusual Options Activity Alerted CALL flow observed 10x contracts at Strike price of $130 Exp on 01/16/2026 with Premium of $27K and showing NEUTRAL Sentiment
0 · Reply
Zinsinus
Zinsinus Oct. 3 at 3:17 PM
$INSM Beastmode!!!!! making $
0 · Reply
MedDeviceGuy85
MedDeviceGuy85 Oct. 3 at 2:50 PM
1 · Reply
Dy2ski
Dy2ski Oct. 3 at 2:30 PM
$INSM When you see the strong 6 month chart of the $XBI, $INSM is also riding this momentum, to saying nothing about all of their success, executions and probabilities. Absolute, sweet spot.
0 · Reply
pianoman439
pianoman439 Oct. 3 at 12:22 PM
$INSM Did we see this one? -Evercore raises Insmed target to $180 from $110 Outperform
3 · Reply
GolfProLife
GolfProLife Oct. 3 at 12:12 PM
$INSM https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-insm/insmed/news/analyzing-insmed-stock-after-positive-fda-filing-news-and-tr Great article! ERS seeming enough to change many analysts price targets to much higher! Company is forecasted to be in the multi billions a year in revenues in next five years 👀
0 · Reply
BioTechHealthX
BioTechHealthX Oct. 3 at 8:04 AM
$INSM FDA approves Brinsupri as the first therapy for NCFB. Insmed rallies to $149.20, with Wall Street setting price targets as high as $240. https://biotechhealthx.com/biotech-news/insmed-insm-jumps-to-149-20-high-after-fda-approval-of-brinsupri/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 3 at 7:17 AM
Enter: $INSM NOV 21 2025 $150 CALLS Buy in Price: $9.30 - $9.49 Take Profit: $13.67 Stop Bleeding: $8.35 ROI Potential: 44% Exit Within: 253 Minutes https://moneygroup.us/alerts
0 · Reply
WAJeff
WAJeff Oct. 2 at 8:18 PM
Had more $INSM sell at $152, $152.85 52 week high
1 · Reply
NightBreeze
NightBreeze Oct. 2 at 7:51 PM
$INSM That Skeleton Key is worth a few coins
0 · Reply
bemore
bemore Oct. 2 at 7:41 PM
$INSM 200 by the end o the year, a buy out 300, 400 in 2 years if not bought out.
0 · Reply
pianoman439
pianoman439 Oct. 2 at 7:19 PM
$INSM breakout city 💥
2 · Reply